Here's Why Ventas (VTR) is a Strong Momentum Stock

Zacks has highlighted Ventas (VTR), an S&P 500 healthcare REIT, as a strong momentum stock. Despite a Zacks #3 (Hold) rank, VTR holds an 'A' Momentum Style Score and a 'B' VGM Score, driven by a 0.6% share price increase over the past four weeks and recent upward revisions to its fiscal 2025 earnings consensus estimate, which rose $0.02 to $3.45 per share. This suggests a positive earnings outlook and potential for continued outperformance based on momentum.

Analysis

Ventas, Inc. (VTR), a healthcare-focused real estate investment trust, is demonstrating strong momentum signals despite a neutral overall rating from Zacks. The company has been assigned a Zacks Rank of #3 (Hold), but scores an 'A' for Momentum and a 'B' for its composite VGM (Value, Growth, Momentum) score. This positive momentum is evidenced by a 0.6% share price increase over the past four weeks, which is further supported by positive shifts in its earnings outlook. Specifically, for fiscal 2025, two analysts have revised their earnings estimates upward in the last 60 days, causing the Zacks Consensus Estimate to increase by $0.02 to $3.45 per share. The company also has a track record of consistently meeting or slightly exceeding expectations, with an average earnings surprise of 1.2%. The combination of a neutral rank with high momentum and VGM scores suggests that while the stock may not qualify as a 'Strong Buy' under the full Zacks criteria, its recent performance and improving earnings forecast make it a noteworthy candidate for investors prioritizing momentum strategies.

Key Decisions for Investors

• Investors with a momentum-focused strategy should consider VTR, given its 'A' Momentum Style Score is supported by positive share price trends and upward revisions to its fiscal 2025 earnings consensus.
• The neutral Zacks #3 (Hold) rank suggests a balanced approach is warranted, indicating that while momentum is favorable, the stock may lack the catalysts for strong, immediate outperformance across all investment styles.
• Portfolio managers should monitor for continued upward revisions to the $3.45 per share consensus earnings estimate, as the article identifies this as a primary driver for both the stock's rating and its potential price appreciation.